{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:11Z","timestamp":1792000991614,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.03.057","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T12:51:26Z","timestamp":1302871886000},"page":"3863-3872","source":"Crossref","is-referenced-by-count":113,"title":["Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines"],"prefix":"10.1016","volume":"29","author":[{"given":"Rosario Z.","family":"Capeding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imelda A.","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Bomasang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro","family":"Lupisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Forrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Wartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Crevat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.03.057_bib0005","series-title":"Epidemiology of arthropod-borne viral disease","author":"Gubler","year":"1988"},{"key":"10.1016\/j.vaccine.2011.03.057_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-3476(97)70054-4","article-title":"Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention","volume":"131","author":"Kautner","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(97)12483-7","article-title":"Dengue and dengue haemorrhagic fever","volume":"352","author":"Rigau-P\u00e9rez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.03.057_bib0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/pgmj.2004.019638","article-title":"Dengue viral infections","volume":"80","author":"Malavige","year":"2004","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-3156.2000.00562.x","article-title":"Isolation and partial characterization of dengue virus type 2 and 4 strains from dengue fever and dengue haemorrhagic fever patients from Mindanao, Republic of Philippines","volume":"5","author":"Meulen","year":"2000","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.vaccine.2011.03.057_bib0030","unstructured":"World Health Organization. Dengue in the Western Pacific region. http:\/\/www.wpro.who.int\/health_topics\/dengue\/. Updated September 15, 2010. Accessed September 20, 2010."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0035","unstructured":"World Health Organization. Dengue and dengue haemorrhagic fever. Fact sheet number 117. http:\/\/www.who.int\/mediacentre\/factsheets\/fs117\/en\/print.html. Updated March 2009. Accessed September 20, 2010."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4269\/ajtmh.2005.73.796","article-title":"Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution","volume":"73","author":"Salda","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0045","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0050","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","article-title":"Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines","volume":"151","author":"Mantel","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vaccine.2011.03.057_bib0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0035-9203(59)90021-5","article-title":"A plaque technique for the titration of yellow fever virus and antisera","volume":"53","author":"Porterfield","year":"1959","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.99.2.285","article-title":"A plaque reduction test for dengue virus neutralizing antibodies","volume":"99","author":"Russell","year":"1967","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0075","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-na\u00efve adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0080","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-na\u00efve children, adolescents, and adults in Mexico city: randomized controlled phase 1 trial of safety and immunogenicity","volume":"30","author":"Poo","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1708-8305.2007.00158.x","article-title":"Safety of Typhim Vi vaccine in a postmarketing observational study","volume":"14","author":"Marcus","year":"2007","journal-title":"J. Travel Med."},{"key":"10.1016\/j.vaccine.2011.03.057_bib0090","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.vaccine.2005.09.029","article-title":"Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.057_bib0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T06:03:35Z","timestamp":1686031415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":19,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X11004397"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.057","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13200043.14542212","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}